Header Logo

Connection

YESID ALVARADO to Cell Lineage

Back to Details
This is a "connection" page, showing publications YESID ALVARADO has written about Cell Lineage.
YESID ALVARADO
Connection Strength
0.043
Cell Lineage
  1. Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher. Am J Hematol. 2022 Sep; 97(9):1135-1141.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.